In this article published in Research Policy, the authors analyze whether a patent-owner can honor a (F)RAND commitment on a patent if it offers a license to that patent only in a bundle that also includes licenses to patents on which it has not made a (F)RAND commitment. They conclude that it can, but only if the royalty for the bundle does not exceed what would be a (F)RAND royalty for just the (F)RAND-committed patent. To read the article, click the link below.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...